Evolution of the Average Target: Amgen Inc.

Evolution of the Target Price: Amgen Inc.

Changes in Analyst Recommendations: Amgen Inc.

c39eb546267503c582.sepBSEqmA830y4iNYRLdNflryxnGcjsofBDSyTV48RQ.0rs2CziLMIi5rfv8FmK0Zp1fhV6JHlQdBHaN_EI1s1j13zYFPZRCq6yOsA~6b3bb2f7d3a78aaa7df9e84f8aeaf002
08-13 Daiwa Securities Adjusts Price Target on Amgen to $430 From $390, Keeps Outperform Rating MT
08-13 Barclays Adjusts Price Target on Amgen to $380 From $360, Maintains Equalweight Rating MT
08-10 HSBC Adjusts Price Target on Amgen to $445 From $425, Keeps Buy Rating MT
08-07 Citigroup Adjusts Price Target on Amgen to $405 From $345, Maintains Neutral Rating MT
08-06 Rothschild & Co Redburn Adjusts Amgen Price Target to $235 From $220, Maintains Sell Rating MT
08-05 Bernstein Adjusts Price Target on Amgen to $345 From $335, Maintains Market Perform Rating MT
08-05 UBS Adjusts Price Target on Amgen to $440 From $420, Maintains Buy Rating MT
08-05 JPMorgan Adjusts Price Target on Amgen to $350 From $300, Maintains Neutral Rating MT
08-05 Wells Fargo Adjusts Price Target on Amgen to $400 From $390, Maintains Equalweight Rating MT
08-05 Leerink Partners Adjusts Price Target on Amgen to $395 From $355, Maintains Market Perform Rating MT
08-05 TD Cowen Adjusts Price Target on Amgen to $452 From $420, Maintains Buy Rating MT
08-05 Goldman Sachs Adjusts Price Target on Amgen to $450 From $427, Maintains Buy Rating MT
08-05 BMO Capital Adjusts Price Target on Amgen to $450 From $400, Maintains Outperform Rating MT
08-05 Scotiabank Adjusts Price Target on Amgen to $450 From $385, Maintains Sector Outperform Rating MT
08-05 Canaccord Genuity Adjusts Price Target on Amgen to $384 From $366, Maintains Hold Rating MT
08-05 Baird Adjusts Price Target on Amgen to $230 From $215, Maintains Underperform Rating MT
08-05 Oppenheimer Adjusts Price Target on Amgen to $450 From $400, Maintains Outperform Rating MT
08-05 BofA Adjusts Price Target on Amgen to $317 From $312 MT
08-05 RBC Capital Adjusts Price Target on Amgen to $400 From $370, Maintains Outperform Rating MT
08-05 Analyst recommendations: Palantir Technologies, McDonald's, Booking Holdings, Arista Networks, Amgen... Zonebourse
08-05 Morgan Stanley Adjusts Price Target on Amgen to $351 From $333, Maintains Equalweight Rating MT
07-28 Barclays Adjusts Amgen Price Target to $360 From $350, Maintains Equalweight Rating MT
07-20 Goldman Sachs Adjusts Price Target on Amgen to $427 From $425, Maintains Buy Rating MT
07-13 BofA Securities Adjusts Amgen Price Target to $312 From $307 MT
07-13 UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-7.6%
+11.08%
+4.67%
+10.74%
+4.28%
+2.2%
+36.34%
+6.45%
+13.77%
+6.78%
Average +8.87%
Weighted average by Cap. +8.85%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
415.21USD
Average target price
383.66USD
Spread / Average Target
-7.60%
High Price Target
452.00USD
Spread / Highest target
+8.86%
Low Price Target
230.00USD
Spread / Lowest Target
-44.61%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Daiwa Securities
Barclays
HSBC
Citigroup
Rothschild & Co Redburn
RBC Capital Markets
BofA Securities
Oppenheimer
Baird
Canaccord Genuity
Scotiabank
BMO Capital
Goldman Sachs
TD Cowen
Leerink Partners
Wells Fargo Securities
JPMorgan Chase
UBS
Bernstein
Morgan Stanley
Truist Securities
Mizuho Securities
Argus
Piper Sandler
Guggenheim
Deutsche Bank Securities
Cantor Fitzgerald
DZ Bank
DBS Bank
Jefferies & Co.
Redburn Atlantic
William Blair & Co.
Credit Suisse
DA Davidson
SVB Securities LLC
Cowen
Atlantic Equities
SVB Leerink
JPMORGAN Cory Kasimov
RBC Kennen Mackay
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
415.21USD
Average target price
383.66USD
Spread / Average Target
-7.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock
  4. Consensus Amgen Inc.